Bruker at ASMS 2024

June 2 - 6, 2024

Anaheim, CA, USA

Bruker at ASMS 2024: Driving Innovation in Mass Spectrometry

Thank you, Anaheim, and thank you for joining us to make a splash at ASMS 2024. We promised you a California Dreaming, we hope we delivered.

Here's a recap in case you missed it, introducing the all new products and software.

Product Launches

timsTOF Ultra 2: Unmatched sensitivity for deep proteomics for small cells, subcellular organelles, and increased sample loading flexibility

neofleX™: MALDI-TOF system for spatial biology Mass Spec Imaging (MSI) applications.

Further Products

EVOQ® DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry.



ecTOF™ with simultaneous EI and CI ionization in TOF high-resolution mass spectrometry, for ultimate confidence in compound identification with GC-HRMS. 

More Information

Poster Hall ASMS

Download numerous posters from ASMS covering the latest in proteomics, metabolomics, imaging, pharma and applied.

Schedule a consultation

Connect with a Bruker specialist to discuss how our cutting-edge solutions can empower your research. 

ASMS 2024 Posters 

ASMS 2024 Posters

MP 017 Rapid Screening and Quantification of PFAS in Contaminated Soil utilizing DART-MS/MS

MP 055 Improved proteome coverage combined with reproducible quantitation on the timsTOF platform

MP 062 Trapped Ion Mobility Separation (TIMS) in Combination with Scanning Quadrupole Isolation for Data Independent Acquisition in Proteomics

MP 141 Direct Analysis of Petroleum and Biofuels with FT-ICR MS and Direct Ionization Probe APPI

MP 173 A novel approach for monitoring multi-classes of POPs in a single run by GC-Ion Mobility-HRMS

MP 227 Royal jelly's phenolic profile via UPLC-VIP-HESI-TIMS-QTOF-MS: A thorough characterization following a multivariate optimization approach

MP 230 Direct Analysis in Real-Time with High Resolution Mass Spectrometry: A Rapid Tool for Black Truffle Authentication

MP 384 How Clean is “Clean”? Going Above and Beyond the Conventional Check-Clean with a Rapid, DART-MS Protocol

MP 402 TIMS-enabled 4D-Metabolomics workflow for the automated analysis of derivatised analytes

MP 435 DeepCCS: Context-aware prediction of peptide collisional cross section increases peptide recovery for out-of-distribution data-independent acquisition (DIA) datasets

MP 468 In-depth investigation of PFAS occurrence in environmental samples combining LC-VIP HESI-TIMS-QTOF MS with PASEF and untargeted data processing

MP 520 Application of TIMS-MRMS to the study of lipids in human blood plasma

MP 522 Paving the way toward analysis of Caenorhabditis elegansindividuality – Development of single worm lipidomics based on nanoLC-TIMS-MS/MS

MP 537 A system suitability scheme for assessment of longitudinal LC-TIMS-MS performance to promote reproducibility in omics sciences

MP 755 Increasing throughput while maintaining coverage depths in single cell proteomics using the timsTOF Ultra

MP 762 Non-small cell Lung cancer single spheroid analysis using the cellenONE with proteoCHIP EVO 96 workflow on the timsTOF Ultra

MP 815 Optimization of Adeno-Associated Virus peptide mapping using trapped ion mobility spectrometry

TP 021 Rapid Quantitative Screening of 18 Synthetic Cannabinoids in Urine Using DART-MS Analysis

TP 085 Detecting PFAS beyond the Current Regulative Request: a Comprehensive Overview of the Contamination in Water by UPHLC-Ion mobility-HRMS

TP 355 Analysis of Lipid Nanoparticle Components by MALDI Trapped Ion Mobility Spectrometry

TP 369 Probing the Environmental Fortitude of mRNA Lipid Nanoparticles: A TIMS-TOF Insights into Stress-Induced Degradation

TP 381 Analysis of novel Caenorhabditis elegans-specific phosphorylated sphingolipids using LC-TIMS-MS/MS and MassQL

TP 412 Application of Dried Blood Spot Microsampling for High-Throughput  Four-Dimensional Trapped Ion Mobility Spectrometry Lipidomics

TP 558 Dia-PASEF for in-depth immunopeptidomics analysis: Challenges and new opportunities

TP 574 TIMSrescore: timsTOF-optimized PSM rescoring boosts identification rates for immunopeptidomics

TP 580 Advancing Low input Chromatography: Developing a novel Column for Improved Immunopeptidomics IDs

TP 715 Optimizing LC-MS/MS settings for plasma proteomics analysis with cap-flow LC separation and dia-PASEF

TP 722 Turbocharging Discovery: Crafting a High-Speed, High-Efficiency Monolithic Column for Breakneck Single-Cell Analysis

WP 227 The timsTOF Ultra enables deep global ubiquitinomics of ultra-low protein input samples for validating degrader drug targets

WP 370 Combination of fluorescence and IR images with protein and lipid MALDI Imaging allows more insights into disease phenotypes

WP 415 Significantly faster library-free dia-PASEF analysis with a Spectronaut integrated workflow in ProteoScape

WP 422 Longitudinal data quality monitoring enables improvement of quality management practices: a case study in proteomic research utilizing a digital-twin approach

WP 685 Sequence Analysis of Proteins enhanced by TIMS-Enabled Next-Generation MALDI Top-Down Sequencing using a Dedicated Software Workflow

WP 760 dia-PASEF proteomic analysis of HNSCC tumor and stroma enriched sections from FFPE samples prepared with laser capture microdissection

WP 804 Graphical Data Analysis and Sample Comparison of Complex Mesophase Pitches

WP 805 MALDI-TOF MS Analysis of Mechanopolymers and Vitrimers

ThP 089 Dia-PASEF for in-depth immunopeptidomics analysis: Challenges and new opportunities

ThP 419 Integration and joint multivariate analysis of multimodal chemical imaging data on an example case of hepatocellular carcinoma in rat

ThP 459 prmImaging: an integrated workflow for the analysis and interpretation of spatial on-tissue tandem mass spectrometry of lipids

ThP 457 Deep molecular coverage at faster throughput: IR Guided MALDI Imaging in cancer research

ThP 461 Targeted protein imaging of kidney pathologies using MALDI Imaging

ThP 608 Unleashing High Sensitivity: NanoLC Monolithic Columns in 4D Metabolomics and Lipidomics

ThP 755 Evaluating a new Workflow for Top-Down Protein Sequence Confirmation andde novo Sequencing 


For Research Use Only. Not for use in clinical diagnostic procedures.